Category: Latest News
-

Lineage shares edge higher as adjusted EBITDA exceeds expectations
Lineage (NASDAQ:LINE) shares rose around 1.5% after the temperature-controlled warehouse REIT reported second-quarter 2026 results, with adjusted EBITDA coming in ahead of expectations despite posting a GAAP net loss for the quarter. Revenue increased 0.8% year over year to $1.36 billion, reflecting modest growth across the business. Adjusted EBITDA outperforms despite lower margins The company…
-

Northwest Natural tops earnings estimates despite revenue shortfall
Northwest Natural Holding Company (NYSE:NWN) reported second-quarter results that exceeded Wall Street earnings expectations, although quarterly revenue came in below analyst forecasts. The utility company’s shares were little changed following the announcement, edging up 0.06% in after-hours trading. The company posted adjusted earnings of $0.01 per share, outperforming the consensus estimate of a loss of…
-

Taboola shares plunge after earnings miss and weaker revenue outlook
Taboola (NASDAQ:TBLA) shares fell nearly 17% in pre-market trading on Wednesday after the digital advertising company reported second-quarter results that missed Wall Street expectations and issued revenue guidance that came in well below analyst forecasts. The company posted adjusted earnings of $0.01 per share, missing the consensus estimate of $0.05. Quarterly revenue reached $476.8 million,…
-

CVS Health raises 2026 outlook after stronger-than-expected second-quarter results
CVS Health (NYSE:CVS) shares climbed around 5% in pre-market trading on Wednesday after the healthcare company reported second-quarter earnings that comfortably exceeded Wall Street expectations and increased its full-year profit forecast. The company posted earnings of $2.58 per share for the quarter, well above the analyst consensus of $1.83. Revenue rose 7.3% from a year…
-

Match Group shares tumble as revenue miss and weak outlook overshadow earnings beat
Match Group (NASDAQ:MTCH) shares dropped 10.2% in pre-market trading to $37.03 after the online dating company reported second-quarter 2026 results that exceeded earnings expectations but disappointed investors with weaker revenue, declining paying users and cautious forward guidance. The company posted adjusted earnings of $0.70 per share, ahead of Wall Street’s consensus estimate of $0.65. Adjusted…
-

Kratos Defense shares soar after earnings beat and stronger full-year outlook
Kratos Defense & Security (NASDAQ:KTOS) shares jumped 7.8% in pre-market trading after the defense technology company reported second-quarter 2026 results that comfortably exceeded Wall Street expectations and raised its growth outlook for the full year. The company posted adjusted earnings of $0.21 per share, well above the analyst consensus of $0.13, while revenue reached $458.8…
-

Coupang shares slide after revenue miss and cautious outlook disappoint investors
Coupang (NYSE:CPNG) shares fell 5.3% in pre-market trading after the South Korean e-commerce company released second-quarter 2026 results that fell short of revenue expectations and issued guidance pointing to continued pressure on profit margins. The company reported quarterly revenue of $8.9 billion, approximately $170 million below analyst forecasts. Revenue still increased 4% year over year…
-

Samsung and SK Hynix evaluate Chinese chip equipment as U.S. restrictions remain a concern
Samsung Electronics (USOTC:SSNHZ) and SK Hynix (NASDAQ:SKHY) have been testing semiconductor manufacturing equipment supplied by China’s Advanced Micro-Fabrication Equipment (AMEC) at their production facilities in China, according to a Reuters report citing sources familiar with the matter. Shares of both South Korean chipmakers moved higher following the report, with SK Hynix rising 4.9% and Samsung…
-

Novo Nordisk shares fall despite improved outlook as Wegovy sales disappoint
Novo Nordisk (NYSE:NVO) raised its full-year guidance after reporting continued demand for its weight-loss treatments, but weaker-than-expected sales of its oral Wegovy medication and disappointing clinical trial results for a next-generation obesity therapy weighed heavily on investor sentiment. The company’s shares dropped 6% during US trading on Tuesday, while its Copenhagen-listed stock declined 4.2% after…
-

Upstart shares surge after company returns to GAAP profitability
Upstart (NASDAQ:UPST) shares climbed 12.2% in pre-market trading after the AI-powered lending platform reported its strongest quarterly performance in several years, achieving its first GAAP profit since late 2021 and comfortably outperforming market expectations on revenue and loan originations. The results, released after Tuesday’s closing bell, triggered a sharp rally in after-hours trading that continued…